Cardinal buys up Alaris shares:
This article was originally published in Clinica
Executive Summary
Cardinal Health has completed its tender offer for all outstanding shares of common stock of Alaris Medical Systems. As previously announced, Cardinal purchased the shares at a price of $22.35 each in cash as part of its plan to acquire San Diego, California-based Alaris. The final steps to completing the merger - in which the developer of needle-free valves and systems will become a wholly-owned Cardinal subsidiary - is going ahead despite the dark cloud of litigation hanging over Alaris. At the end of last month, ICU Medical had filed a patent lawsuit against San Diego, California-based Alaris concerning the latter's SmartSite and SmartSite Plus needle-free valves and systems (see Clinica No 1113, p 12).